Dysfunctional cognitions in idiopathic environmental intolerances (IEI)-An integrative psychiatric perspective

Toxicology Letters

Volumn 171, Issue 1-2, 2007, Pages 1-9

  Hausteiner, C ^a   Bornschein, S ^a   Zilker, T ^a   Henningsen, P ^a   Forstl H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cognitive processing; Cortical representation; Dysfunctional cognitions; Idiopathic environmental intolerances; Multiple chemical sensitivities; Somatoform disorders

Indexed keywords

ANXIETY DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE CLASSIFICATION; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED PRACTICE; HUMAN; IDIOPATHIC ENVIRONMENTAL INTOLERANCE; MEDICAL RESEARCH; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SOMATOFORM DISORDER; STIMULATION;

COGNITION DISORDERS; HUMANS; MULTIPLE CHEMICAL SENSITIVITY; PSYCHIATRY;

EID: 34250813041     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.04.010     Document Type: Review

References (97)

1. Anon. Multiple chemical sensitivity: a 1999 consensus. Arch. Environ. Health 54 3 (1999) 147-149
2. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision). p. 485.
3. Arnow B.A. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J. Clin. Psychiatry 65 Suppl. 12 (2004) 10-15
4. Arntz A., Rauner M., and van den Hout M. "If I feel anxious, there must be danger": ex-consequentia reasoning in inferring danger in anxiety disorders. Behav. Res. Ther. 33 8 (1995) 917-925
5. Bailer J., Witthoft M., Paul C., Bayerl C., and Rist F. Evidence for overlap between idiopathic environmental intolerance and somatoform disorders. Psychosom. Med. 67 6 (2005) 921-929
6. Bailer J., Witthoft M., Bayerl C., and Rist F. Syndrome stability and psychological predictors of symptom severity in idiopathic environmental intolerance and somatoform disorders. Psychol. Med. 37 2 (2007) 271-281
7. Barsky A.J. Amplification, somatization, and the somatoform disorders. Psychosomatics 33 1 (1992) 28-34
8. Barsky A.J., and Borus J.F. Functional somatic syndromes. Ann. Intern. Med. 130 11 (1999) 910-921
9. Bell I.R., Miller C.S., and Schwartz G.E. An olfactory limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol. Psychiatry 32 (1992) 218-242
10. Benedetti F. Placebo analgesia. Neurol. Sci. 27 Suppl. 2 (2006) S100-S102
11. Bentall R.P., and Kaney S. Content specific information processing and persecutory delusions: an investigation using the emotional Stroop test. Br. J. Med. Psychol. 62 (1989) 355-364
12. Binkley K.E., and Kutcher S. Panic response to sodium lactate infusion in patients with multiple chemical sensitivity syndrome. J. Allergy Clin. Immunol. 99 4 (1997) 570-574
13. Binkley K., King N., Poonai N., Seeman P., Ulpian C., and Kennedy J. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J. Allergy Clin. Immunol. 107 5 (2001) 887-890
14. Black D.W., Okiishi C., Gabel J., and Schlosser S. Psychiatric illness in the first-degree realtives of persons reporting multiple chemical sensitivities. Toxicol. Indust. Health 15 3-4 (1999) 410-414
15. Black D.W., Okiishi C., and Schlosser S. A 9 year follow-up of people diagnosed with multiple chemical sensitivities. Psychosomatics 41 (2000) 253-261
16. Bolt H.M., and Kiesswetter E. Is multiple chemical sensitivity a clinically defined entity?. Toxicol. Lett. 128 (2002) 99-106
17. Bornschein S., Hausteiner C., Drzezga A., Bartenstein P., Schwaiger M., Förstl H., and Zilker Th. PET in patients with clear-cut multiple chemical sensitivity (MCS). Nuklearmed 41 (2002) 233-239
18. Bornschein S., Hausteiner C., Konrad F., Förstl H., and Zilker T. Psychiatric morbidity and toxic burden in patients with environmental illness: a controlled study. Psychosom. Med. 68 1 (2006) 104-109
19. Brennan J.H., and Hemsley D.R. Illusory correlations in paranoid and non-paranoid schizophrenia. Br. J. Clin. Psychol. 23 (1984) 225-226
20. Brosschot J.F. Cognitive-emotional sensitization and somatic health complaints. Scand. J. Psychol. 43 2 (2002) 113-121
21. Brosschot J.F., Pieper S., and Thayer J.F. Expanding stress theory: prolonged activation and perseverative cognition. Psychoneuroendocrinology 30 (2005) 1043-1049
22. Brown R.J. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol. Bull. 130 5 (2004) 793-812
23. Brown R.J., Schrag A., and Trimble M.R. Dissociation, childhood interpersonal trauma, and family functioning in patients with somatization disorder. Am. J. Psychiatry 162 5 (2005) 899-905
24. Brown R.J., Poliakoff E., and Kirkman M.A. Somatoform dissociation and somatosensory amplification are differentially associated with attention to the tactile modality following exposure to body-related stimuli. J. Psychosom. Res. 62 2 (2007) 159-165
25. Brugger P., and Graves R.E. Testing vs. believing hypotheses: magical ideation in the judgment of contingencies. Cogn. Neuropsychiatry 2 (1997) 251-272
26. Caccappolo-van Vliet E., Kelly-McNeil K., Natelson B., Kipen H., and Fiedler N. Anxiety sensitivity and depression in multiple chemical sensitivities and asthma. J. Occup. Environ. Med. 44 10 (2002) 890-901
27. Ciccone D.S., and Natelson B.H. Comorbid illness in women with chronic fatigue syndrome: a test of the single syndome hypothesis. Psychosom. Med. 65 2 (2003) 268-275
28. Clark D.M. Anxiety disorders: why they persist and how to treat them. Behav. Res. Ther. 37 Suppl. 1 (1999) S5-S27
29. Craig T.K., Boardman A.P., Mills K., Daly-Jones O., and Drake H. The South London Somatization Study I: longitudinal course and the influence of early life experiences. Br. J. Psychiatry 163 (1993) 579-588
30. Cullen M.R. The worker with multiple chemical sensitivities: an overview. Occup. Med. State Art Rev. 2 (1987) 655-662
31. Damasio A.R. Descartes' Error. Emotion, Reason and the Human Brain (1994), Putnam's Son, New York
32. Derbyshire S.W., Whalley M.G., Stenger V.A., and Oakley D.A. Cerebral activation during hypnotically induced and imagined pain. NeuroImage 23 1 (2004) 392-401
33. Duddu V., Isaac M.K., and Chaturvedi S.K. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int. Rev. Psychiatry 18 1 (2006) 25-33
34. Fear C.F., Sharp H., and Healy D. Cognitive processes in delusional disorders. Br. J. Psychiatry 168 (1996) 61-67
35. Fiedler N., Maccia C., and Kipen H. Evaluation of chemically sensitive patients. J. Occup. Med. 34 5 (1992) 529-538
36. Freeman D., Garety P.A., Kuipers E., Fowler D., and Bebbington P.E. A cognitive model of persecutory delusions. Br. J. Clin. Psychol. 41 Pt 4 (2002) 331-347
37. Garcia-Campayo J., Sanz-Carrillo C., Baringo T., and Ceballos C. SPECT scan in somatization disorder patients: an exploratory study of eleven cases. Aust. N.Z. J. Psychiatry 35 3 (2001) 359-363
38. Garety P.A., Hemsley D.R., and Wessely S. Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. J. Nerv. Ment. Dis. 179 4 (1991) 194-201
39. Hausteiner C., Bornschein S., Hansen J., Förstl H., and Zilker T. Self-reported chemical sensitivity in Germany: A population-based survey. Int. J. Hyg. Environ. Health 208 (2005) 271-278
40. Hausteiner C., Mergeay A., Bornschein S., Zilker T., and Förstl H. New aspects of psychiatric morbidity in idiopathic environmental intolerances. J. Occup. Environ. Med. 48 1 (2006) 76-82
41. Henningsen P., and Priebe S. New environmental illnesses: what are their characteristics?. Psychother. Psychosom. 72 5 (2003) 231-234
42. Henningsen P. The body in the brain: towards a representational neurobiology of somatoform disorders. Acta Neuropsychiatry 15 (2003) 157-160
43. Hiller W., and Fichter M.M. High utilizers of medical care: a crucial subgroup among somatizing patients. J. Psychosom. Res. 56 4 (2004) 437-443
44. IPCS, 1996. Report of multiple chemical sensitivities (MCS) workshop. Berlin, Germany, 21-23 February, 1996. International Program on Chemical Safety (IPCS) in Collaboration with the German Federal Ministry of Health, Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV) and the Federal Environmental Agency (UBA), PCS/96.29, 8/1996.
45. Jewett D.L., Fein G., and Greenberg M.H. A double-blind study of symptom provocation to determine food sensitivity. N. Engl. J. Med. 323 7 (1990) 429-433
46. Kaney S., and Bentall R.P. Persecutory delusions and attributional style. Br. J. Med. Psychol. 62 (1989) 191-198
47. Kirmayer L.J., Robbins J.M., and Paris J. Somatoform disorders: personality and the social matrix of somatic distress. J. Abnorm. Psychol. 103 1 (1994) 125-136
48. Kirmayer L.J. Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment. J. Clin. Psychiatry 62 Suppl. 13 (2001) 22-28
49. Kirmayer L.J., Groleau D., Looper K.J., and Dao M.D. Explaining medically unexplained symptoms. Can. J. Psychiatry 49 10 (2004) 663-672
50. Kirmayer L.J., and Looper K.J. Abnormal illness behaviour: physiological, psychological and social dimensions of coping with distress. Curr. Opin. Psychiatry 19 1 (2006) 54-60
51. Köppel C., and Fahron G. Toxicological and neuropsychological findings in patients presenting to an environmental toxicology service. J. Toxicol. Clin. Toxicol. 33 (1995) 625-629
52. Kreutzer R. MCS: the status of population-based research. Int. J. Hyg. Environ. Health 205 5 (2002) 411-414
53. Labarge X.S., and McCaffrey R.J. Multiple chemical sensitivity: a review of the theoretical and research literature. Neuropsychol. Rev. 10 4 (2000) 183-211
54. Marcus D.K., Gurley J.R., Marchi M.M., and Bauer C. Cognitive and perceptual variables in hypochondriasis and health anxiety: a systematic review. Clin. Psychol. Rev. 27 2 (2007) 127-139
55. Miller C.S. Toxicant-induced loss of tolerance: An emerging theory of disease?. Environ. Health Perspect. 105 Suppl. 2 (1997) 445-453
56. Mohr C., Hubener F., and Laska M. Deviant olfactory experiences, magical ideation, and olfactory sensitivity: a study with healthy German and Japanese subjects. Psychiatry Res. 111 1 (2002) 21-33
57. Mogg K., and Bradley B.P. A cognitive-motivational analysis of anxiety. Behav. Res. Ther. 36 9 (1998) 809-848
58. Nakao M., Barsky A.J., Nishikitani M., Yano E., and Murata K. Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300). Neurosci. Lett. 415 2 (2007) 185-189
59. Naliboff B.D., Derbyshire S.W., Munakata J., Berman S., Mandelkern M., Chang L., and Mayer E.A. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom. Med. 63 (2001) 365-375
60. Nettleton S. "I just want permission to be ill": Towards a sociology of medically unexplained symptoms. Soc. Sci. Med. 62 (2006) 1167-1178
61. Nimnuan C., Rabe-Hesketh S., Wessely S., and Hotopf M. How many functional somatic syndromes?. J. Psychosom. Res. 51 4 (2001) 549-557
62. Nordin S., Martinkauppi M., Olofsson J., Hummel T., Millqvist E., and Bende M. Chemosensory perception and event-related potentials in self-reported chemical hypersensitivity. Int. J. Psychophysiol. 55 2 (2005) 243-255
63. Pall M.L. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med. Hypotheses 57 2 (2001) 139-145
64. Papo D., Eberlein-Koenig B., Berreseheim H.W., Huss-Marp J., Grimm V., Ring J., Behrendt H., and Winneke G. Chemosensory function and psychological profile in patients with multiple chemical sensitivity: comparison with odor-sensitive and asymptomatic controls. J. Psychosom. Res. 60 (2006) 199-209
65. Pennebaker J.W. Psychological bases of symptom reporting: perceptual and emotional aspects of chemical sensitivity. Toxicol. Indust. Health 10 4-5 (1994) 497-511
66. Price D.D., Craggs J., Verne G.N., Perlstein W.M., and Robinson M.E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127 1-2 (2007) 63-72
67. Rainville P., Duncan G.H., Price D.D., Carrier B., and Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277 (1997) 968-971
68. Rainville P., Bushnell M.C., and Duncan G.H. Representation of acute and persistent pain in the human CNS: potential implications for chemical intolerance. Ann. N.Y. Acad. Sci. 933 (2001) 130-141
69. Rief W., Hiller W., and Margraf J. Cognitive aspects of hypochondriasis and the somatization syndrome. J. Abnorm. Psychol. 107 4 (1998) 587-595
70. Rief W., Hessel A., and Braehler E. Somatization symptoms and hypochondriacal features in the general population. Psychosom. Med. 63 4 (2001) 595-602
71. Rief W., Ihle D., and Pilger F. A new approach to assess illness behaviour. J. Psychosom. Res. 54 5 (2003) 405-414
72. Rief W., and Barsky A.J. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 30 (2005) 996-1002
73. Rizzolatti G., and Craighero L. The mirror-neuron system. Ann. Rev. Neurosci. 27 (2004) 169-192
74. Rosenberg S.J., Freedman M.R., Schmaling K.B., and Rose C. Personality styles of patients asserting environmental illness. J. Occup. Med. 32 8 (1990) 678-681
75. Salkovskis P.M. The cognitive approach to anxiety: threat beliefs, safety-seeking behaviour, and the special case of health anxiety and obsessions. In: Salvovskis P.M. (Ed). Frontiers of Cognitive Therapy (1996), Guilford, New York 48-74
76. Schottenfeld R.S. Workers with multiple chemical sensitivities: a psychiatric approach to diagnosis and treatment. Occup. Med. 2 4 (1987) 739-753
77. Shusterman D., Balmes J., and Cone J. Behavioral sensitization to irritants/odorants after acute overexposures. J. Occup. Med. 30 (1988) 565-567
78. Simon G.E., Daniell W., Stockbridge H., Claypoole K., and Rosenstock L. Immunologic, psychological and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann. Intern. Med. 119 (1993) 97-103
79. Staudenmayer H., Selner J.C., and Buhr M.P. Double-blind provocation chamber challenges in 20 patients presenting with "multiple chemical sensitivity". Regul. Toxicol. Pharmacol. 18 1 (1993) 44-53
80. Staudenmayer H., Selner M.E., and Selner J.C. Adult sequelae of childhood abuse presenting as environmental illness. Ann. Allergy 71 (1993) 538-546
81. Staudenmayer H. Environmental Illness: Myth and Reality (1999), Lewis, Boca Raton, FL
82. Staudenmayer H., Binkley K.E., Leznoff A., and Phillips S. Idiopathic environmental intolerance. Part 2. A causation analysis applying Bradford Hill's criteria to the psychogenic theory. Toxicol. Rev. 22 4 (2003) 247-261
83. Staudenmayer H., and Phillips S. MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance. J. Psychosom. Res. 62 1 (2007) 61-72
84. Stewart D.E., and Raskin J. Psychiatric assessment of patients with "20th-century disease" ("total allergy syndrome"). Can. Med. Assoc. J. 133 (1985) 1001-1006
85. Stockenius S., and Brugger P. Perceived electrosensitivity and magical ideation. Percept. Mot. Skills 90 3 Pt 1 (2000) 899-900
86. Stuart S., and Noyes Jr. R. Attachment and interpersonal communication in somatization. Psychosomatics 40 1 (1999) 34-43
87. Terr A.I. Clinical ecology in the workplace. J. Occup. Med. 31 (1989) 257-261
88. Thayer J.F., and Brosschot J.F. Psychosomatics and psychopathology: looking up and down from the brain. Psychoneuroendocrinology 30 (2005) 1050-1058
89. Tonori H., Aizawa Y., Ojima M., Miyata M., Ishikawa S., and Sakabe K. Anxiety and depressive states in multiple chemical sensitivity. Tokohu J. Exp. Med. 193 2 (2001) 115-126
90. Ursin H., and Eriksen H.R. Sensitization, subjective health complaints, and sustained arousal. Ann. N.Y. Acad. Sci. 933 (2003) 119-129
91. Ursin H., and Eriksen H.R. The cognitive activation theory of stress. Psychoneuroendocrinology 29 (2004) 567-592
92. Van den Bergh O., Devriese S., Winters W., Veulemans H., Nemery B., Eelen P., and Van de Woestijne K.P. Acquiring symptoms in response to odors: a learning perspective on multiple chemical sensitivity. Ann. N.Y. Acad. Sci. 933 (2001) 278-290
93. Waller E., Scheidt C.E., and Hartmann A. Attachment representation and illness behavior in somatoform disorders. J. Nerv. Ment. Dis. 192 3 (2004) 200-209
94. WHO Media Centre Fact sheet No. 196, December 2005.
95. Wiesmüller G.A., Ebel H., Hornberg C., Kwan O., and Friel J. Are syndromes in environmental medicine variants of somatoform disorders?. Med. Hypotheses 61 4 (2003) 419-423
96. Williams C.W., and Lees-Haley P.R. Perceived toxic exposure: a review of four cognitive influences on perception of illness. J. Soc. Behav. Personal 8 (1993) 489-506
97. Witthoft M., Gerlach A.L., and Bailer J. Selective attention, memory bias, and symptom perception in idiopathic environmental intolerance and somatoform disorders. J. Abnorm. Psychol. 115 3 (2006) 397-407